Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2005
08/03/2005EP1558572A2 Novel compounds and their use as prar-modulators
08/03/2005EP1558566A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
08/03/2005EP1558267A1 Use of fosinopril to reduce cardiovascular events in dialysis patients
08/03/2005EP1558256A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
08/03/2005EP1558252A2 Substituted furo 2,3-b] pyridine derivatives
08/03/2005EP1558245A2 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
08/03/2005EP1558226A2 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
08/03/2005EP1558080A2 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
08/03/2005EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
08/03/2005EP1359975A4 Ocular iontophoretic device and method of use
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005EP1071671B1 Triazolones with a neuroprotective action
08/03/2005EP0946550B1 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL)METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
08/03/2005EP0825259B1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649897A FALP proteins
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649893A Dipeptide derivatives having a N-terminal 2-thiocyl group as vasopeptidase inhibitors
08/03/2005CN1649884A Novel azacyclic ethynyl derivatives
08/03/2005CN1649877A Process for the preparation of clopidogrel
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives
08/03/2005CN1649870A 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649840A Non-peptidic BRS-3 agonists
08/03/2005CN1649834A Novel propionic acid derivative
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649621A Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
08/03/2005CN1649616A Methods and compositions for the treatment of ischemia
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649608A Composition comprising the extract of cistanche deserticola Y.C. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects
08/03/2005CN1649607A A process for the extraction of anthocyanins from black rice and composition thereof
08/03/2005CN1649596A Treatment of hypertension in women receiving hormone replacement therapy
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones
08/03/2005CN1649592A Pharmaceutical composition
08/03/2005CN1649586A Heterocyclic amide derivatives for the treatment of diabetes and other diseases
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure
08/03/2005CN1649575A Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
08/03/2005CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/03/2005CN1649569A Controlled release dosage forms
08/03/2005CN1649551A Drug-delivery endovascular stent and method for treating restenosis
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1647844A Method and device for preparing flavone agent
08/03/2005CN1647816A Process for preparing decumbent corydalis tuber total alkaloid and its preparation and quality detecting method
08/03/2005CN1647814A Pill for cerebral hemorrhage and its formula
08/03/2005CN1647807A Plaster special for carbuncle, cellulitis, sore, furuncle and pile and its preparing method
08/03/2005CN1213055C Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments
08/03/2005CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213033C Crystalline bis [(E)-7[4-(4-(4-fluorophenyl)-6-isopropy-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3R,5S-3,5-dihydroxyhept-6-enoic acid] calcium salt
08/03/2005CN1213029C S-Ht receptor agonist and its preparing method for salt
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1212861C Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-K B inhibitors as the active ingredient
08/03/2005CN1212854C Compound prunella spike capsule and preparation process thereof
08/03/2005CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors
08/03/2005CN1212831C Pharmaceutical preparations
08/03/2005CA2479385A1 Use of propargylamine as neuroprotective agent
08/02/2005US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy
08/02/2005US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
08/02/2005US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
08/02/2005US6924356 Human protein HHEPU32
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924301 Composition for treating or preventing arrhythmia
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924296 Antithrombotic agents
08/02/2005US6924295 Hetereocyclic amines such as 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid ethyl ester, used as peroxisome proliferator activated receptor modulators; hyperlipemia; diabetis;
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924283 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents
1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 1595